IP Library Granted Patent US 11,045,471
Granted Patent B2
US 11,045,471 · App. 16/820,773 · Granted Jun 29, 2021

Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant

Inventors: Daisuke Yagyu (Chiba, JP); Yuko Nakagami (Fujisawa, JP); Ryota Niibayashi (Honjo, JP); Eiko Kato (Tokyo, JP)
Assignee: SHOWA DENKO K.K.
A61K31/513A61K8/49A61K8/4953A61P17/16A61Q19/02A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,471
App. No.
16/820,773
Granted
Jun 29, 2021
Kind
B2
Abstract

The present invention provides an agent containing an orotic acid derivative that has high solubility in solvent and has superior physiological activity. The agent of the present invention is a melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promoter or wrinkle ameliorant containing as an active ingredient thereof an orotic acid derivative represented by the following general formula (1) or a salt thereof. In formula (1), R preferably represents a side chain of glutamic acid, glycine, histidine or aspartic acid. [In formula (1), R represents a side chain of a naturally-occurring amino acid and R may form, together with a nitrogen atom adjacent thereto through a single carbon atom, a hetero ring.]

Claims (15)

1. A composition comprising, as an active ingredient thereof, an orotic acid derivative represented by the following general formula (1) or a salt thereof and containing 1% by weight to 99.9% by weight of water:

wherein, R represents a side chain of a hydrophilic naturally-occurring amino acid selected from the group consisting of serine, threonine, cysteine, asparagine, glutamine, and histidine.

2. The composition according to claim 1 , further comprising carriers or additives pharmaceutically or cosmetically acceptable for use as external skin preparations or cosmetics.

3. The composition according to claim 1 , wherein the concentration of the orotic acid derivative or salt thereof is 1.0×10 −6 % (w/v) to 10% (w/v).

4. The composition according to claim 1 , wherein a pH of the composition is 2 to 8.

5. The composition according to claim 1 , wherein R in the formula (1) represents a side chain of histidine.

6. The composition according to claim 5 , further comprising carriers or additives pharmaceutically or cosmetically acceptable for use as external skin preparations or cosmetics.

7. The composition according to claim 5 , wherein the concentration of the orotic acid derivative or salt thereof is 1.0×10 −6 % (w/v) to 10% (w/v).

8. The composition according to claim 5 , wherein a pH of the composition is 2 to 8.

9. A composition comprising, as an active ingredient thereof, an orotic acid derivative represented by the following general formula (1) or a salt thereof:

wherein, R represents a side chain of a hydrophilic naturally-occurring amino acid selected from the group consisting of serine, threonine, cysteine, asparagine, glutamine, and histidine; and

the concentration of the orotic acid derivative or salt thereof is 1.0×10 −6 % (w/v) to 10% (w/v).

10. The composition according to claim 9 , further comprising carriers or additives pharmaceutically or cosmetically acceptable for use as external skin preparations or cosmetics.

11. The composition according to claim 9 , wherein a pH of the composition is 2 to 8.

12. The composition according to claim 9 , wherein R in the formula (1) represents a side chain of histidine.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 14, 2024
From: RESONAC CORPORATION
To: RESONAC CORPORATION
Reel/Frame 066599/0037 →
CHANGE OF NAME Recorded Jun 23, 2023
From: SHOWA DENKO K.K.
To: RESONAC CORPORATION
Reel/Frame 064082/0513 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2020
From: YAGYU, DAISUKE; NAKAGAMI, YUKO; NIIBAYASHI, RYOTA; KATO, EIKO
To: SHOWA DENKO K.K.
Reel/Frame 052183/0236 →
Priority Claims (1)
JP 2016-139465 · Jul 14, 2016 · national
Continuity (2)
Division 16314960
Related Publication 20200215069A1 · Jul 9, 2020